Australia markets close in 31 minutes

iTeos Therapeutics, Inc. (ITOS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
17.54-0.32 (-1.79%)
At close: 04:00PM EDT
17.54 0.00 (0.00%)
After hours: 04:07PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
454,229
12,595
267,630
344,775
0
-
Operating expenses
Research development
89,324
113,300
97,359
59,369
29,900
-
Selling general and administrative
42,444
50,396
43,947
40,505
15,340
-
Total operating expenses
128,929
157,482
138,043
89,693
39,307
-
Operating income or loss
325,300
-144,887
129,587
255,082
-39,307
-
Interest expense
-
-
-
-
-
0
Total other income/expenses net
24,734
4,083
7,788
1,304
1,217
-
Income before tax
350,034
-109,030
148,736
256,464
-38,090
-
Income tax expense
88,963
3,612
52,084
41,943
-57
-
Income from continuing operations
261,071
-112,642
96,652
214,521
-38,033
-
Net income
261,071
-112,642
96,652
214,521
-38,033
-
Net income available to common shareholders
261,071
-112,642
96,652
214,521
-43,402
-
Basic EPS
-1.72
-
2.72
6.10
-2.88
-2.68
Diluted EPS
-1.75
-
2.56
5.68
-2.88
-2.68
Basic average shares
35,715
-
35,552
35,181
15,080
9,912
Diluted average shares
36,195
-
37,767
37,775
15,080
9,912